Abstract
BackgroundRecent data shows safety and efficacy of dual-drug regimens (2DR). We evaluated viro-immunological characteristics in gut-associated lymphoid tissues (GALT) and peripheral blood mononuclear cells (PBMCs) in individuals switched to 2DR...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
